Login / Signup

Effect of Previous Anticoagulant Treatment on Risk of COVID-19.

Maruxa Zapata-CachafeiroÁngela Prieto-CampoManuel Portela RomeroEduardo Carracedo-MartínezMartina Lema-OreiroMaría Piñeiro-LamasSomnath ChaudhuriÁngel Salgado-BarreiraAdolfo Figueiras
Published in: Drug safety (2022)
The results of this study have shown that antivitamin K anticoagulants and direct-acting anticoagulants do not increase the risk of progression to more severe stages. Antivitamin K consumption was associated with a lower risk of hospitalization and susceptibility to infection.
Keyphrases
  • coronavirus disease
  • sars cov
  • venous thromboembolism
  • atrial fibrillation
  • replacement therapy